CD62E+ EEV–monocyte complexes were more numerous during exacerbations than in remission while the number of CD54+ EEV–monocyte complexes remained unchanged, suggesting that the former would be a better marker for monitoring MS. The gene discussed is ICAM1; the disease is myeloid sarcoma.